Zydus Lifesciences is set to acquire Agenus Inc.'s biologics manufacturing facilities in California for $75 million upfront ...

Biotech firm Biocon on Tuesday said it has received approval from the government authorities for a generic diabetes ...

Biocon has secured Indian regulatory approval for its generic Liraglutide drug substance and product, a version of Victoza, ...

Agenus (NASDAQ:AGEN) stock surges 21% after partnering with Zydus Lifesciences for cancer therapies, botensilimab and ...

In a two-pronged expansion move, Zydus enters the U.S. biologics CDMO market and secures India-Sri Lanka rights for next-gen ...

Zydus Lifesciences acquires 5.9% stake in Agenus Inc for $16 million, marking entry into the global biologics contract ...

The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global ...

Since Trump’s re-election in November, the Trump Organization — his family’s real estate empire — has announced 12 new ...

Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its ...

Zydus Lifesciences Ltd enters global biologics CDMO market with acquisition of Agenus Inc.'s manufacturing facilities in the ...

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US ...

Biocon receives CDSCO approval for its generic Liraglutide, a diabetes medication. The drug will be launched in India soon, ...